No ADT for Men With Prostate Cancer, Comorbidities

Forgoing androgen deprivation therapy cuts rather than raises overall and cardiac mortality in certain patients with prostate cancer, depending on their comorbidities, according to a “Research Letter to the Editor” published in the Journal of the American Medical Association.
Source: Caring for the Ages - Category: Health Management Authors: Source Type: news